Contributors
Latest:
A Guide for Comprehensive Cancer Control ProgramsThis article outlines three areas where LGBTQ patients and their caregivers may face challenges and how the Comprehensive Cancer Control Programs (CCCP) can address these needs. Written by Dr. Amari Pearson- Fields, the former Comprehensive Cancer Program Director for Washington DC.
Latest:
Staying Informed and Empowered as A Patient with CancerCutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.
Latest:
Carolyn Presley on the Implications of Screening on Lung Cancer CareCarolyn Presley discusses the implications of screening on diagnosis and treatment of lung cancer.
Latest:
Developing a Patient-Friendly Clinical Trial Search EngineKathryn Burn, head of Partnerships and Research at Smart Patients, discusses her organization's role in the National Cancer Moonshot Initiative.
Latest:
From One to Many: The Growing Treatment Landscape of HER2-Positive Breast CancerTwo decades ago, a patient with HER2-positive breast cancer had a single targeted drug option. Now a plethora of new and emerging treatments fill the landscape.
Latest:
Exploring Therapeutic Vaccine in Head and Neck CancerJoshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.
Latest:
How Running Helped A Stomach Cancer Survivor ThriveAfter beating stomach cancer, a grandmother transformed herself into a competitive amateur athlete to stay active and healthy.
Latest:
A Life Beyond CancerCURE chooses the winning essay for it 2009 Extraordinary Healer Award for Oncology Nursing.
Latest:
Finding the Right Therapy for High-Risk Mantle Cell LymphomaA certain group of patients may not be candidates for common therapies, explained Bijal D. Shah, M.D.
Latest:
A Miracle in The Time of CoronavirusEven the smallest of realizations can feel like a miracle.
Latest:
Targeted Therapies for Advanced MCL May Improve Outcomes as Front-line TreatmentMantle cell lymphoma remains incurable, despite researchers’ best efforts. However, new treatment options show promise in the relapsed/refractory setting and may improve patient outcomes if moved to the front-line, according to Dr. Reem Karmali.
Latest:
The HaircutLatest:
The Benefits of Personal TrainingExercise and nutrition intervention for patients with cancer could help with symptoms from treatment.
Latest:
Taking a Risk: The Path to Recovery from Cancer with Clinical TrialsBeing a part of a groundbreaking clinical trial put me on the path to recovery. I continue to eat healthy, exercise regularly and do my part to ensure my cancer does not return.
Latest:
There Is Magic in CancerThere is magic in the realization that the best of humanity is lifting you up, praying for you, holding you close, reaching out and touching your life in whatever way they can.
Latest:
Surprised by Side EffectsHere, a reader shares her experience with dealing with the side effects of hormonal therapy.
Latest:
Anees B. Chagpar on What to Expect After Contralateral Prophylactic MastectomyAnees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven, discusses what a patient can expect following a contralateral prophylactic mastectomy.
Latest:
Immunotherapy Brings 'Radical Change' to Lung Cancer TreatmentMarina Chiara Garassino, M.D., talks about how immunotherapy agents have vastly improved the treatment field of patients with non-small cell lung cancer.
Latest:
Recognizing the Importance of Cancer PreventionCarolyn R. Aldige, founder and president of the Prevent Cancer Foundation, discusses the importance of cancer prevention.
Latest:
Bob Dickey on the Value of Relationships From Climbing Mount KilimanjaroBob Dickey, a survivor of multiple myeloma, discusses the importance of the relationships formed when he and more than 80 other people climbed Mount Kilimanjaro.
Latest:
Helping Patients Navigate the Clinical Trial SpaceThe Leukemia & Lymphoma Society's (LLS) Clinical Trial Support Center helps patients with blood cancers find clinical trials that are right for them.
Latest:
ADT May Offer Some Protection From COVID-19 in Men with Prostate CancerA PCF-funded study of men with prostate cancer in Italy suggests that men with prostate cancer who were taking ADT were 4 times less likely to be infected with the coronavirus than men who were not on ADT (androgen deprivation therapy), and 5 times less likely to die. These new findings are a game-changer and may lead to potential treatments for COVID-19, even in men without prostate cancer.
Latest:
Addressing Questions From Newly Diagnosed Patients with Multiple MyelomaNaturally, newly diagnosed patients with multiple myeloma have a lot of questions for their physicians. Dr. Joshua Richter had the time to discuss some of them.
